MK2461 in Patients With Advanced Cancer (2461-001)(COMPLETED)

Clinical trial NCT00518739 · COMPLETED

Trial details

NCT number: NCT00518739
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Cancer

Start date: 2007-02-01
Primary completion: 2008-12-01
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.